Skip to main content

Advertisement

Table 2 Prognosis between patients with no statin and statin groups

From: Prestroke statins use reduces oxidized low density lipoprotein levels and improves clinical outcomes in patients with atrial fibrillation related acute ischemic stroke

  No prestroke statins use group (136) No prestroke statins use group (106) OR (95% CI) P*
Death, n (%) 47 (34.6) 23 (21.7) 0.53 (0.29–0.94) 0.029
Major disability, n (%) 54/89 (60.7) 32/83 (38.6) 0.41 (0.22–0.75) 0.004
Major disability+death, n (%) 101 (74.3) 55 (51.9) 0.37 (0.22–0.64) < 0.001
  1. *Comparison between no pre-stroke statins use group and pre-stroke statins use group. Categorical variables are expressed as frequency (percent) for P values, prognosis was compared between the 2 subgroups by univariate analysis using Pearson χ2 test